Northern California residents can now join the efforts to develop a COVID-19 vaccine. Kaiser Permanente began recruiting participants for an advanced clinical vaccine trial at the beginning of August. Dr. Nicola Klein, Director of the Kaiser Permanente Vaccine Study Center, spoke with KRCB's Adia White. Adia starts by asking what happens during a so-called "phase three" trial, and when a safe and effective vaccine might be ready for general use.  

 

 

 

 

 

We provide local news updates on The North Bay Report Tuesday-Friday at 6:45, 8:45 a.m., and 5:30 p.m. on KRCB radio 91 and 90.9. Here's our North Bay Report episode for Friday, August 28. Subscribe to The North Bay Report podcast to listen on the go.